AI assistant
Sending…
HARROW, INC. — Director's Dealing 2008
Sep 26, 2008
31774_dirs_2008-09-25_f1a59531-478b-4ea9-a056-a26b7f608065.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TRANSDEL PHARMACEUTICALS INC (TDLP.OB)
CIK: 0001360214
Period of Report: 2008-09-23
Reporting Person: THORNLEY ANTHONY S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-09-23 | Common stock | P | 3000 | $1.25 | Acquired | 57900 | Direct |
| 2008-09-25 | Common stock | P | 3000 | $1.05 | Acquired | 60900 | Direct |
More from HARROW, INC.
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Regulatory Filings
2026
Feb 2
Director's Dealing
2026
Jan 8